Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
29. September 2023 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Synlogic to Participate in Chardan’s Genetic Medicines Conference
21. September 2023 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
AlphaTime Acquisition Corp Announces Pricing of $60 Million Initial Public Offering
30. Dezember 2022 16:05 ET
|
AlphaTime Acquisition Corp.
Cayman Islands, Dec. 30, 2022 (GLOBE NEWSWIRE) -- AlphaTime Acquisition Corp (the “Company”) today announced the pricing of its initial public offering of 6,000,000 units at a price of $10.00 per...
Chardan NexTech Acquisition 2 Corp. Shareholders Approve Previously Announced Business Combination with Dragonfly Energy, Corp.
06. Oktober 2022 16:05 ET
|
Dragonfly Energy Corp.
RENO, Nev., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Chardan NexTech Acquisition 2 Corp. (“CNTQ”) (Nasdaq: CNTQ), a publicly traded special purpose acquisition company, today announced that its...
IMUNON to Present at Chardan’s 6th Annual Genetic Medicines Conference
27. September 2022 08:30 ET
|
Imunon, Inc.
LAWRENCEVILLE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company, today announced that Dr. Corinne Le Goff, President and Chief...
Synlogic To Present at Upcoming Investor and Industry Conferences
24. Februar 2022 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
WinVest Acquisition Corp. Announces Closing of $100 Million Initial Public Offering
17. September 2021 12:32 ET
|
WinVest Acquisition Corp.
Cambridge, MA, Sept. 17, 2021 (GLOBE NEWSWIRE) -- WinVest Acquisition Corp. (NASDAQ: WINVU, the “Company”) announced today that it closed its initial public offering of 10,000,000 units at a price...
Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
28. September 2020 07:00 ET
|
Precision Biosciences
DURHAM, N.C., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies...
Beamz Interactive, Inc. Signs Agreement With New York-Based Chardan Capital Markets
15. April 2014 08:01 ET
|
Beamz Interactive, Inc.
SCOTTSDALE, AZ--(Marketwired - Apr 15, 2014) - Beamz Interactive, Inc. (OTCQB: BZIC), a leading developer of state-of-the-art interactive music products, signed an agreement with Chardan Capital...
Worlds Finalizes Settlement With Investor Group, Retains Chardan Capital
22. Juli 2013 07:30 ET
|
Worlds Inc.
BOSTON, MA--(Marketwired - Jul 22, 2013) - Worlds Inc. (OTCBB: WDDD) received a majority of shareholder votes at its annual shareholder meeting on July 18th in support of Worlds' recent request to...